Acne vulgaris Epidemiology forecast to 2030

July 31 03:52 2020
Acne vulgaris Epidemiology forecast to 2030

 

(Albany, US) DelveInsight has launched a new report on Acne vulgaris Epidemiology

DelveInsight’s Acne vulgarisc Epidemiology Forecast to 2030 report delivers an in-depth understanding of the disease, historical and forecasted Acne vulgarisc epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Acne vulgaris (AV) is a common chronic skin disease involving blockage and/or inflammation of pilosebaceous units (hair follicles and their accompanying sebaceous gland). Acne can present as noninflammatory lesions, inflammatory lesions, or a mixture of both, affecting mostly the face but also the back and chest. AV appears during early puberty when androgenic stimulation triggers excessive production of sebum and abnormal follicular keratinization, colonization by a Gram-positive bacterium (Propionibacterium acnes) and local inflammation.

 

 

Request for free sample page: – https://www.delveinsight.com/sample-request/acne-vulgaris-epidemiology-forecast

 

Acne Vulgaris Epidemiology

Common symptoms of Acne Vulgaris are: whiteheads (closed plugged pores), blackheads (open plugged pores),small red, tender bumps (papules), pimples (pustules), large, solid, painful lumps beneath the surface of the skin (nodules), pus-filled lumps beneath the surface of the skin (cystic lesions).

 

Based on the extent of severity of acne, Acne Vulgaris is classified as:

  • ·         Mild
  • ·         Moderate
  • ·         Severe

 

It is more common in females as compare to males

 

Key facts of the report

  • Acne Vulgaris affects ~85% of young adults aged 12–25 years. Acne consistently represents the top three most prevalent skin conditions in the general population, as found in large studies within the UK, France, and the USA.
  • Acne is one of the most common skin disorders worldwide and occurs primarily at puberty with a prevalence of almost 95 percent. Although it is principally a disorder of adolescence, the prevalence of adult patients with acne, particularly adult women with acne, is increasing.
  • Women are affected more by acne (85%) than men (15%); family history represents one of the main risk factors (70%); the persistent form of acne is more prevalent (70.7%) than the late-onset form; mild acne is the predominant form (87%); and there is a large number of smokers among adults with acne than among younger individuals with acne.
  • AV is the most common skin condition in the United States, affecting up to 50 million Americans annually. It can occur at any stage of life and may continue into one’s 30s and 40s.

 

Acne vulgarisc Detailed Epidemiology Segmentation

The Acne vulgarisc epidemiology covered in the report provides historical as well as forecasted Acne vulgarisc epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030. The DelveInsight Acne vulgarisc report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

 

Scope of the Report

  • The Acne vulgarisc report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Acne vulgarisc Epidemiology Report and Model provide an overview of the risk factors and global trends of Acne vulgarisc in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Acne vulgarisc in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Acne vulgarisc
  • The report provides the segmentation of the Acne vulgarisc epidemiology

 

Request for free sample page: – https://www.delveinsight.com/sample-request/acne-vulgaris-epidemiology-forecast

 

Table of content

1. Key Insights 

2. Executive Summary of Acne vulgarisc

3. Acne vulgarisc: Disease Background and Overview

4. Patient Journey

5. Epidemiology and Patient Population

6. Treatment Algorithm, Current Treatment, and Medical Practices

7. KOL Views

8. Unmet Needs

9.  Appendix

0. DelveInsight Capabilities

11. Disclaimer

12. about DelveInsight

 

Why should you buy this report?

 

  • The Acne vulgarisc Epidemiology report will allow the user to –
  • Develop business strategies by understanding the trends shaping and driving the global Acne vulgarisc market
  • Quantify patient populations in the global Acne vulgarisc market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Acne vulgarisc therapeutics in each of the markets covered
  • Understand the magnitude of Acne vulgarisc population by its epidemiology
  • The Acne vulgarisc Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

 

Related Reports

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/